MARINA OLE Trademark

Trademark Overview


On Thursday, February 17, 2022, a trademark application was filed for MARINA OLE with the United States Patent and Trademark Office. The USPTO has given the MARINA OLE trademark a serial number of 97272575. The federal status of this trademark filing is REGISTERED as of Tuesday, November 28, 2023. This trademark is owned by Avidity Biosciences Inc.. The MARINA OLE trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:

oligonucleotide-conjugate based therapies, oligonucleotide-antibody conjugate based therapies, and oligonucleotide-antibody fragment conjugate based therapies for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, neuromuscular, rare muscle diseases, cardiomyopathies, heart muscle diseases, muscular dystrophies, muscle atrophy, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders

Providing medical and scientific research information in the fields of pharmaceuticals and biotechnology
marina ole

General Information


Serial Number97272575
Word MarkMARINA OLE
Filing DateThursday, February 17, 2022
Status700 - REGISTERED
Status DateTuesday, November 28, 2023
Registration Number7231783
Registration DateTuesday, November 28, 2023
Mark Drawing3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, June 28, 2022

Trademark Statements


Description of MarkThe mark consists of MARINA text with 3 parallel wavy lines on top of one another to its right overlapping the "O" in the OLE text.
Goods and Servicesoligonucleotide-conjugate based therapies, oligonucleotide-antibody conjugate based therapies, and oligonucleotide-antibody fragment conjugate based therapies for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, neuromuscular, rare muscle diseases, cardiomyopathies, heart muscle diseases, muscular dystrophies, muscle atrophy, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders
Goods and ServicesProviding medical and scientific research information in the fields of pharmaceuticals and biotechnology

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, February 23, 2022
Primary Code005
First Use Anywhere DateMonday, October 3, 2022
First Use In Commerce DateMonday, October 3, 2022

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateWednesday, February 23, 2022
Primary Code042
First Use Anywhere DateMonday, October 3, 2022
First Use In Commerce DateMonday, October 3, 2022

Trademark Owner History


Party NameAvidity Biosciences Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92121

Party NameAvidity Biosciences Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92121

Party NameAvidity Biosciences Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92121

Trademark Events


Event DateEvent Description
Tuesday, November 28, 2023NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, November 28, 2023REGISTERED-PRINCIPAL REGISTER
Thursday, October 26, 2023NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Wednesday, October 25, 2023ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Saturday, September 16, 2023STATEMENT OF USE PROCESSING COMPLETE
Wednesday, September 6, 2023USE AMENDMENT FILED
Saturday, September 16, 2023CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, September 6, 2023TEAS STATEMENT OF USE RECEIVED
Tuesday, August 8, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, August 4, 2023SOU EXTENSION 2 GRANTED
Friday, August 4, 2023SOU EXTENSION 2 FILED
Friday, August 4, 2023SOU TEAS EXTENSION RECEIVED
Wednesday, February 15, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, February 13, 2023SOU EXTENSION 1 GRANTED
Monday, February 13, 2023SOU EXTENSION 1 FILED
Monday, February 13, 2023SOU TEAS EXTENSION RECEIVED
Tuesday, August 23, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, June 28, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, June 28, 2022PUBLISHED FOR OPPOSITION
Wednesday, June 8, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, May 19, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, May 11, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, May 11, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, May 11, 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, April 22, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, April 22, 2022NON-FINAL ACTION E-MAILED
Friday, April 22, 2022NON-FINAL ACTION WRITTEN
Friday, April 22, 2022ASSIGNED TO EXAMINER
Thursday, February 24, 2022NOTICE OF DESIGN SEARCH CODE E-MAILED
Wednesday, February 23, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, February 21, 2022NEW APPLICATION ENTERED